Helmer Scientific, a leading U.S. manufacturer and distributor of medical equipment, is pleased to announce the recent acquisition of the ThermoLine Product Lines from ThermoGenesis Corp. The acquisition is part of Helmer Scientific's growth strategy and a continuing commitment to providing high quality products to the medical and blood bank community.
The acquisition is an enhancement of the Helmer core biological sample processing product lines. Bruce King, President of Helmer Scientific, said of the acquisition; "This line acquisition is focused on providing a solution to our customers who have voiced a need for a reliable rapid plasma freezing system. Helmer Scientifics' long-standing service orientation and commitment to world-wide customer relationships, combined with our technical expertise in blood storage and processing equipment, uniquely position Helmer to support ThermoGenesis' longtime customers with a service and support infrastructure for both their freezing and thawing devices.
ThermoGenesis, a leading supplier of enabling technologies for the processing, storage, and administration of cell therapies, announced the sale today. "As was the case with our divestiture of the CryoSeal product line in mid-2012, this transaction is part of our long-term strategy to focus on our core business of developing enabling technologies for the stem cell regernerative medicine market," said Matthew Plavan, Chief Executive Officer of ThermoGenesis.
About Helmer Scientific
Helmer Scientific is a world leader in providing specialized scientific products that aid customers in their efforts to improve and save lives. Our purpose is to provide opportunities for personal growth and development while positively impacting the world community. Helmer provides solutions for storage and processing while serving customers within hospitals, diagnostic labs, pharmaceutical and biotech companies, universities, research institutions, and government facilities. Our Brand Promise of targeted, customer-focused innovation, world-class quality and reliability, and relationship-based service sets us apart.
Helmer Global Initiatives (HGI) is operated by Helmer to make an impact on society and bring aid and justice for poor vulnerable people through our philanthropic and volunteer initiatives. Additional information about Helmer is available at www.helmerinc.com.
About ThermoGenesis
ThermoGenesis Corp. (NASDAQ:KOOL) is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the separation, preservation, and delivery of cell and tissue therapy product.
